SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-029769
Filing Date
2021-05-25
Accepted
2021-05-25 16:11:04
Documents
8
Period of Report
2021-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20210525.htm 8-K 39419
2 EX-1.1 achv-ex11_134.htm EX-1.1 209042
3 EX-5.1 achv-ex51_50.htm EX-5.1 14038
4 EX-99.1 achv-ex991_33.htm EX-99.1 14070
5 EX-99.2 achv-ex992_34.htm EX-99.2 13323
6 GRAPHIC gthxh4fcirxt000001.jpg GRAPHIC 10708
7 GRAPHIC glvaf0cpkffl000001.jpg GRAPHIC 11441
8 GRAPHIC gz3m3tdzd5vo000001.jpg GRAPHIC 11818
  Complete submission text file 0001564590-21-029769.txt   338540
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 21960722
SIC: 2835 In Vitro & In Vivo Diagnostic Substances